Serina Therapeutics
Quarterly Financials
| Values in thousands | 2024-12-31 | 2024-09-30 | 2024-06-30 | 2024-03-31 |
|---|---|---|---|---|
Revenue | $0 | $0 | $51 | $5 |
Gross Profit | -6 | -20 | ||
EBITDA | -2,679 | 1,455 | 5,476 | -9,313 |
EBIT | -2,735 | 1,399 | 5,419 | -9,338 |
Net Income | -2,740 | 1,410 | 5,204 | -9,437 |
Net Change In Cash | 0 | 0 | 51 | 5 |
Free Cash Flow | -4,594 | -2,965 | -8,009 | -1,591 |
Cash | 3,672 | 3,185 | 6,064 | 8,706 |
Basic Shares | 10,751 | 10,751 | 10,157 | 2,790 |
Annual Financials
| Values in thousands | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|
Revenue | $0 | $142 | $500 | $3,039 |
Gross Profit | -29 | 355 | 2,889 | |
EBITDA | -9,780 | -2,604 | -1,587 | |
EBIT | -9,911 | -2,736 | -1,718 | |
Net Income | -11,141 | -14,803 | -2,682 | -1,264 |
Net Change In Cash | 0 | 142 | 500 | 3,039 |
Free Cash Flow | -17,159 | -7,800 | -2,085 | -2,359 |
Cash | 3,672 | 345 | 532 | 314 |
Basic Shares | 8,892 | 8,413 | 1,078 | 1,077 |
Earnings Calls
| Quarter | EPS |
|---|---|
2024-12-31 | -$0.35 |
2024-09-30 | $0.13 |
2024-06-30 | $0.51 |
2024-03-31 | -$3.38 |
